Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study
Abstract
Background Survivors of malignant disease in childhood who have had radiotherapy to the head, neck, or upper thorax have an increased risk of subsequent primary thyroid cancer, but the magnitude of risk over the therapeutic dose range has not been well established. We aimed to quantify the long-term risk of thyroid cancer after radiotherapy and chemotherapy.Methods In a nested case-control study, 69 cases with pathologically confirmed thyroid cancer and 265 matched controls without thyroid cancer were identified from 14,054 5-year survivors of cancer during childhood from the Childhood Cancer Survivor Study cohort. Childhood cancers were diagnosed between 1970 and 1986 with cohort follow-up to 2000.Findings Risk of thyroid cancer increased with radiation doses up to 20-29 Gy (odds ratio 9.8 [95% CI 3.2-34.8]). At doses greater than 30 Gy, a fall in the dose-response relation was seen. Both the increased and decreased risks were more pronounced in those diagnosed with a first primary malignant disease before age 10 years than in those older than 10 years. Furthermore, the fall in risk remained when those diagnosed with Hodgkin's lymphoma were excluded. Chemotherapy for the first cancer was not associated with thyroid-cancer risk, and it did not modify the effect of radiotherapy. 29 (42%) cases had a first diagnosis of Hodgkin's lymphoma compared with 49 (19%) controls. 11 (42%) of those who had Hodgkin's lymphoma had subsequent thyroid cancers smaller than 1 cm compared with six (17%) of those who had other types of childhood cancer (p=0.07).Interpretation The reduction in radiation dose-response for risk of thyroid cancer after childhood exposure to thyroid doses higher than 30 Gy is consistent with a cell-killing effect. Standard long-term follow-up of patients who have had Hodgkin's lymphoma for detection of thyroid cancer should also be undertaken for survivors of any cancer during childhood who received radiotherapy to the thorax or head and neck region.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The risk of thyroid neoplasia is greatest with exposure to low-level external radiation (0.1-25 Gy; ~0.09-30 μCi/g or 3.33-1110 Bq/g), not with the higher administered activities used to treat GD.
“The risk of thyroid neoplasia is greatest with exposure to low-level external radiation (0.1-25 Gy; *0.09-30 lCi/g or 3.33-1110 Bq/g) (314,315,352,354,357), not with the higher administered activities used to treat GD.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [357]
The citation lists haven’t been fetched yet
References 59 · Cited by 366
- Authors
- Sigurdson, A. J., Ronckers, C. M., Mertens, A. C., Stovall, M., Smith, S. A., Liu, Y., Berkow, R. L., Hammond, S., Neglia, J. P., Meadows, A. T., Sklar, C. A., Robison, L. L., & Inskip, P. D.
- Affiliations
- National Institutes of Health (US)
- University of Minnesota (US)
- The University of Texas MD Anderson Cancer Center (US)
- Fred Hutch Cancer Center (US)
- University of Alabama at Birmingham (US)
- The Ohio State University (US)
- Children's Hospital of Philadelphia (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Sigurdson, Alice J
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 365
- Issue
- 9476
- Pages
- 2014-2023
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2006491639
- Cited by
- 366
- References
- 59
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 8 · 2020: 11 · 2019: 11 · 2018: 11 · 2017: 17 · 2016: 20 · 2015: 33 · 2014: 26 · 2013: 23 · 2012: 25
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Cancer Institute (CA-55727, U24CA055727)
- Topics
- Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- primary thyroid cancer, childhood cancer survivors, radiotherapy, radiation dose-response, Hodgkin's disease, chemotherapy, second primary malignancy, head and neck radiotherapy, long-term follow-up, Childhood Cancer Survivor Study
- MeSH terms
- Adolescent, Adult, Child, Dose-Response Relationship, Radiation, Female, Humans, Male, Neoplasms, Radiation-Induced, Radiotherapy Dosage, Thyroid Gland, Thyroid Neoplasms, Case-Control Studies, Neoplasms, Second Primary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review